JENNIFER GOODIN: Open Payments
NPI 1215687199 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 75 payments from 25 companies in 2025. Trend: 2023 $1,811 · 2024 $3,208 · 2025 $1,441
Food & beverage: $1,441
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $212 |
| Novo Nordisk Inc | 11 | $185 |
| QOL Medical, LLC | 4 | $140 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $105 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Abbott Laboratories | 4 | $74 |
| Exact Sciences Corporation | 3 | $60 |
| Lilly USA, LLC | 3 | $60 |
| Corcept Therapeutics | 3 | $50 |
Products named: Sucraid, Wegovy, XIFAXAN, VRAYLAR, ENTYVIO, FREESTYLE LIBRE 3, CREON, JARDIANCE.
Industry payments across OH — which companies pay providers there.
